. Umscheid, C.A. et al. (2011) Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs.
Definitions used to describe antimicrobial resistance in hospitals
Antimicrobial resistance is the capacity of bacteria to survive exposure to a defined concentration of an antimicrobial substance 1, 2 .
However, in hospitals antimicrobial resistance may have multiple definitions according to the scientific discipline and the goals involved 3,4 : * Clinical definition: the bacteria survive an adequate treatment with an antibiotic. * Pharmacological definition: the bacteria survive a range of concentrations expressing the various amounts of an antibiotic present in the different compartments of the body when the antibiotic is administered at the recommended dose. * Microbiological and molecular definition: the bacteria have a mechanism or gene that governs a higher minimum inhibitory concentration (MIC) than the original or wild bacteria. In hospitals this may become an infection control issue with plasmid mediated resistant organisms and requires molecular testing, for example, detection of various genes such as MecA in Staphylococcus aureus, VanA or VanB genes in Enterococcus species, with carbapenemase resistance in Enterobacteriaceae family or Pseudomonas species with the detection of beta-lactamase resistant genes such as bla IMP/VIM , bla NDM , bla KPC etc. indicate that in a hospital environment for survival purposes, for a bacterium, it is better to be resistant than virulent 6 .
Antibiotic susceptibility testing methods used in Australia
Data from the Royal College of Pathologists of Australasia Quality Assurance Program Microbiology (RCPAQAP Microbiology) indicate that many laboratories in Australia use a number of different antibiotic susceptibility testing methods for various isolated organisms that are potential pathogen to detect resistance 7 . Methods range from rapid automated instruments that use commercial materials and devices (Vitek Systems -bioMerieux or Phoenix -BD Diagnostics) to manual methods that provide flexibility and cost savings, such as disc diffusion and gradient diffusion methods, for example, Etest (bioMerieux or AB BIODISK) or MICE (Thermo-Fisher, Scientific) 1 . Results from the RCPAQAP Microbiology data also show that in many laboratories the test method used also varies with the type of organism being tested and the site of isolation 7 .
Interpretation of antibiotic susceptibility test results in Australia
Susceptibility tests results are usually interpreted by the laboratory prior to releasing a report to the clinician or attending physician. In Australia current data from the RCPAQAP Microbiology indicates that three standardised susceptibility test methods are commonly used when interpreting susceptibility tests based on a quantifiable result either by disc zone sizes or MIC 8 . These three standardised methods are:
(1) The American-based Clinical Laboratory Standard Institute (CLSI, formerly NCCLS) method; (2) The Australian-based Antibiotic Susceptibility Testing using the CDS method (first published in 1975, the Seventh Edition released in 2013) 9 ; and (3) The European Committee on Antimicrobial Susceptibility Testing (EUCAST).
Most medical laboratories interpret susceptibility test using the CLSI method (approximately 80%) followed by the CDS method (approximately 16%) and a smaller number use EUCAST 
Performance of antibiotic susceptibility test methods in laboratories
In most laboratories in Australia (and some overseas), as shown in In most hospitals due to infection control priorities, phenotypic resistance is later confirmed by further using molecular testing in certain organisms showing unusual resistance. It is important to remember when using molecular methods to detect resistance that phenotypic test methods are based on antimicrobial activity (i.e. the MIC) and breakpoints that predict a quantifiable susceptibility and resistance, while genotypic test methods are based on the detection of a resistance gene (or its potential product) and are not quantifiable and predict potential resistance not susceptibility 6 .
Future directions and current methods of antibiotic susceptibility testing in hospitals in Australia
Standardised antimicrobial susceptibility testing methods such as CLSI, CDS or EUCAST provide reliable in vitro results when used mutations, acquisitions and expression mechanisms that result in many resistances and targeting an individual resistance mechanism is a problem 1 . Genome sequencing of isolates is fruitful in some instances and appears to work well for some laboratories that have access to such technology, but to add to my previous discussion, the detection of a gene or its product is not a quantifiable MIC and may (or may not) predict resistance not certain susceptibility or expression 10 .
Conclusion
In hospitals, a variety of laboratory methods can be used to measure the in vitro susceptibility of bacteria to antimicrobial agents. Standardised antibiotic susceptibility testing methods such as CLSI, CDS and EUCAST as phenotypic references indicate susceptibility and resistance of bacterial isolates. This will continue to be clinically important for years to come with the emergence of new unpredictable antimicrobial resistances. RCPAQAP Microbiology offers many laboratories an external susceptibility performance program were results can be compared with other participants and accuracy determined by using different standardised methods. The aim of the program is to assess the reliability of susceptibility methods used by participating laboratories and thereby promote a high standard of laboratory practice. The program is available to all laboratories in Australia, New Zealand and other countries 7 .
